-
1
-
-
0020509916
-
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss
-
Parfitt A.M., Mathews C.H., Villanueva A.R., Kleerekoper M., Frame B., and Rao D.S. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J. Clin. Invest. 72 (1983) 1396-1409
-
(1983)
J. Clin. Invest.
, vol.72
, pp. 1396-1409
-
-
Parfitt, A.M.1
Mathews, C.H.2
Villanueva, A.R.3
Kleerekoper, M.4
Frame, B.5
Rao, D.S.6
-
2
-
-
0031689775
-
Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial
-
Greenspan S.L., Parker R.A., Ferguson L., Rosen H.N., Maitland-Ramsey L., and Karpf D.B. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J. Bone Miner. Res. 13 (1998) 1431-1438
-
(1998)
J. Bone Miner. Res.
, vol.13
, pp. 1431-1438
-
-
Greenspan, S.L.1
Parker, R.A.2
Ferguson, L.3
Rosen, H.N.4
Maitland-Ramsey, L.5
Karpf, D.B.6
-
3
-
-
0032929449
-
A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover
-
Garnero P., Darte C., and Delmas P.D. A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. Bone 24 (1999) 603-609
-
(1999)
Bone
, vol.24
, pp. 603-609
-
-
Garnero, P.1
Darte, C.2
Delmas, P.D.3
-
4
-
-
0033306407
-
Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study
-
Ravn P., Hosking D., Thompson D., Cizza G., Wasnich R.D., McClung M., et al. Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J. Clin. Endocrinol. Metab. 84 (1999) 2363-2368
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, pp. 2363-2368
-
-
Ravn, P.1
Hosking, D.2
Thompson, D.3
Cizza, G.4
Wasnich, R.D.5
McClung, M.6
-
5
-
-
0034121540
-
Monitoring individual response to hormone replacement therapy with bone markers
-
Delmas P.D., Hardy P., Garnero P., and Dain M. Monitoring individual response to hormone replacement therapy with bone markers. Bone 26 (2000) 553-560
-
(2000)
Bone
, vol.26
, pp. 553-560
-
-
Delmas, P.D.1
Hardy, P.2
Garnero, P.3
Dain, M.4
-
6
-
-
0033105942
-
Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group
-
Ravn P., Clemmesen B., and Christiansen C. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group. Bone 24 (1999) 237-244
-
(1999)
Bone
, vol.24
, pp. 237-244
-
-
Ravn, P.1
Clemmesen, B.2
Christiansen, C.3
-
7
-
-
0029923080
-
Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy
-
Riggs B.L., Melton III L.J., and O'Fallon W.M. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 18 (1996) 197S-201S
-
(1996)
Bone
, vol.18
-
-
Riggs, B.L.1
Melton III, L.J.2
O'Fallon, W.M.3
-
8
-
-
0003062649
-
Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density
-
Chesnut III C.H., Bell N.H., Clark G.S., Drinkwater B.L., English S.C., Johnson Jr. C.C., et al. Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am. J. Med. 102 (1997) 29-37
-
(1997)
Am. J. Med.
, vol.102
, pp. 29-37
-
-
Chesnut III, C.H.1
Bell, N.H.2
Clark, G.S.3
Drinkwater, B.L.4
English, S.C.5
Johnson Jr., C.C.6
-
9
-
-
0035664686
-
Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis
-
Bjarnason N.H., Sarkar S., Duong T., Mitlak B., Delmas P.D., and Christiansen C. Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporos. Int. 12 (2001) 922-930
-
(2001)
Osteoporos. Int.
, vol.12
, pp. 922-930
-
-
Bjarnason, N.H.1
Sarkar, S.2
Duong, T.3
Mitlak, B.4
Delmas, P.D.5
Christiansen, C.6
-
10
-
-
0141625900
-
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate
-
Eastell R., Barton I., Hannon R.A., Chines A., Garnero P., and Delmas P.D. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J. Bone Miner. Res. 18 (2003) 1051-1056
-
(2003)
J. Bone Miner. Res.
, vol.18
, pp. 1051-1056
-
-
Eastell, R.1
Barton, I.2
Hannon, R.A.3
Chines, A.4
Garnero, P.5
Delmas, P.D.6
-
11
-
-
0842265895
-
Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk
-
Reginster J.Y., Sarkar S., Zegels B., Henrotin Y., Bruyere O., Agnusdei D., et al. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. Bone 34 (2004) 344-351
-
(2004)
Bone
, vol.34
, pp. 344-351
-
-
Reginster, J.Y.1
Sarkar, S.2
Zegels, B.3
Henrotin, Y.4
Bruyere, O.5
Agnusdei, D.6
-
12
-
-
2942739433
-
Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk
-
Sarkar S., Reginster J.Y., Crans G.C., Diez-Perez A., Pinette K., and Delmas P. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J. Bone Miner. Res. 19 (2004) 394-401
-
(2004)
J. Bone Miner. Res.
, vol.19
, pp. 394-401
-
-
Sarkar, S.1
Reginster, J.Y.2
Crans, G.C.3
Diez-Perez, A.4
Pinette, K.5
Delmas, P.6
-
13
-
-
13144306555
-
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial
-
Bauer D.C., Black D.M., Garnero P., Hochberg M., Ott S., Orloff J., et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J. Bone Miner. Res. 19 (2004) 1250-1258
-
(2004)
J. Bone Miner. Res.
, vol.19
, pp. 1250-1258
-
-
Bauer, D.C.1
Black, D.M.2
Garnero, P.3
Hochberg, M.4
Ott, S.5
Orloff, J.6
-
14
-
-
33744916321
-
Pre-treatment bone turnover and fracture efficacy of alendronate: the fracture intervention trial
-
Bauer D.C., Garnero P., Hochberg M., Santora A.C., Delmas P., Ewing S., et al. Pre-treatment bone turnover and fracture efficacy of alendronate: the fracture intervention trial. J. Bone Miner. Res. 18 Suppl 2 (2003) S55
-
(2003)
J. Bone Miner. Res.
, vol.18
, Issue.SUPPL. 2
-
-
Bauer, D.C.1
Garnero, P.2
Hochberg, M.3
Santora, A.C.4
Delmas, P.5
Ewing, S.6
-
15
-
-
33744930649
-
Ibandronate is highly efficacious in postmenopausal women with high baseline bone turnover rates
-
Chesnut III C.H., Delmas P.D., Christiansen C., Mahoney P., and Schimmer R.C. Ibandronate is highly efficacious in postmenopausal women with high baseline bone turnover rates. Osteoporos. Int. 13 Suppl. 1 (2004) S15
-
(2004)
Osteoporos. Int.
, vol.13
, Issue.SUPPL. 1
-
-
Chesnut III, C.H.1
Delmas, P.D.2
Christiansen, C.3
Mahoney, P.4
Schimmer, R.C.5
-
16
-
-
1642397685
-
Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate
-
Seibel M.J., Naganathan V., Barton I., and Grauer A. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. J. Bone Miner. Res. 19 (2004) 323-329
-
(2004)
J. Bone Miner. Res.
, vol.19
, pp. 323-329
-
-
Seibel, M.J.1
Naganathan, V.2
Barton, I.3
Grauer, A.4
-
17
-
-
19044364417
-
Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
-
Chen P., Satterwhite J.H., Licata A.A., Lewiecki E.M., Sipos A.A., Misurski D.M., et al. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J. Bone Miner. Res. 20 (2005) 962-970
-
(2005)
J. Bone Miner. Res.
, vol.20
, pp. 962-970
-
-
Chen, P.1
Satterwhite, J.H.2
Licata, A.A.3
Lewiecki, E.M.4
Sipos, A.A.5
Misurski, D.M.6
-
18
-
-
0141684971
-
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
-
Black D.M., Greenspan S.L., Ensrud K.E., Palermo L., McGowan J.A., Lang T.F., et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N. Engl. J. Med. 349 (2003) 1207-1215
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 1207-1215
-
-
Black, D.M.1
Greenspan, S.L.2
Ensrud, K.E.3
Palermo, L.4
McGowan, J.A.5
Lang, T.F.6
-
19
-
-
0141573538
-
Parathyroid hormone plus alendronate-A combination that does not add up
-
Khosla S. Parathyroid hormone plus alendronate-A combination that does not add up. N. Engl. J. Med. 349 (2003) 1277-1279
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 1277-1279
-
-
Khosla, S.1
-
20
-
-
0035837553
-
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., and Reginster J.Y. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344 (2001) 1434-1441
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.D.2
Zanchetta, J.R.3
Prince, R.4
Gaich, G.A.5
Reginster, J.Y.6
-
22
-
-
0030865111
-
Comparative calibration without a gold standard
-
Lu Y., Ye K., Mathur A.K., Hui S., Fuerst T.P., and Genant H.K. Comparative calibration without a gold standard. Stat. Med. 16 (1997) 1889-1905
-
(1997)
Stat. Med.
, vol.16
, pp. 1889-1905
-
-
Lu, Y.1
Ye, K.2
Mathur, A.K.3
Hui, S.4
Fuerst, T.P.5
Genant, H.K.6
-
23
-
-
15844376474
-
Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts
-
Lu Y., Mathur A.K., Blunt B.A., Gluer C.C., Will A.S., Fuerst T.P., et al. Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts. J. Bone Miner. Res. 11 (1996) 626-637
-
(1996)
J. Bone Miner. Res.
, vol.11
, pp. 626-637
-
-
Lu, Y.1
Mathur, A.K.2
Blunt, B.A.3
Gluer, C.C.4
Will, A.S.5
Fuerst, T.P.6
-
24
-
-
10144251796
-
Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study
-
Garnero P., Hausherr E., Chapuy M.C., Marcelli C., Grandjean H., Muller C., et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J. Bone Miner. Res. 11 (1996) 1531-1538
-
(1996)
J. Bone Miner. Res.
, vol.11
, pp. 1531-1538
-
-
Garnero, P.1
Hausherr, E.2
Chapuy, M.C.3
Marcelli, C.4
Grandjean, H.5
Muller, C.6
-
25
-
-
0037216436
-
The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis
-
Marcus R., Wang O., Satterwhite J., and Mitlak B. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J. Bone Miner. Res. 18 (2003) 18-23
-
(2003)
J. Bone Miner. Res.
, vol.18
, pp. 18-23
-
-
Marcus, R.1
Wang, O.2
Satterwhite, J.3
Mitlak, B.4
-
26
-
-
0021268975
-
Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis
-
Brown J.P., Delmas P.D., Malaval L., Edouard C., Chapuy M.C., and Meunier P.J. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1 (1984) 1091-1093
-
(1984)
Lancet
, vol.1
, pp. 1091-1093
-
-
Brown, J.P.1
Delmas, P.D.2
Malaval, L.3
Edouard, C.4
Chapuy, M.C.5
Meunier, P.J.6
-
27
-
-
0033982356
-
Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study
-
Ross P.D., Kress B.C., Parson R.E., Wasnich R.D., Armour K.A., and Mizrahi I.A. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos. Int. 11 (2000) 76-82
-
(2000)
Osteoporos. Int.
, vol.11
, pp. 76-82
-
-
Ross, P.D.1
Kress, B.C.2
Parson, R.E.3
Wasnich, R.D.4
Armour, K.A.5
Mizrahi, I.A.6
|